Display options
Cite
Simon P, Camenga DR, Kong G, et al. Youth E-cigarette, Blunt, and Other Tobacco Use Profiles: Does SES Matter?. Tob Regul Sci. 2017;3(1):115-127doi: 10.18001/TRS.3.1.12.
Simon, P., Camenga, D. R., Kong, G., Connell, C. M., Morean, M. E., Cavallo, D. A., & Krishnan-Sarin, S. (2017). Youth E-cigarette, Blunt, and Other Tobacco Use Profiles: Does SES Matter?. Tobacco regulatory science, 3(1), 115-127. https://doi.org/10.18001/TRS.3.1.12
Simon, Patricia, et al. "Youth E-cigarette, Blunt, and Other Tobacco Use Profiles: Does SES Matter?." Tobacco regulatory science vol. 3,1 (2017): 115-127. doi: https://doi.org/10.18001/TRS.3.1.12
Simon P, Camenga DR, Kong G, Connell CM, Morean ME, Cavallo DA, Krishnan-Sarin S. Youth E-cigarette, Blunt, and Other Tobacco Use Profiles: Does SES Matter?. Tob Regul Sci. 2017 Jan;3(1):115-127. doi: 10.18001/TRS.3.1.12. Epub 2017 Jan 01. PMID: 29082301; PMCID: PMC5654631.
Copy Download .nbib Format: NLM
Share it on

Tob Regul Sci. 2017 Jan;3(1):115-127. doi: 10.18001/TRS.3.1.12. Epub 2017 Jan 01.

Youth E-cigarette, Blunt, and Other Tobacco Use Profiles: Does SES Matter?.

Tobacco regulatory science

Patricia Simon, Deepa R Camenga, Grace Kong, Christian M Connell, Meghan E Morean, Dana A Cavallo, Suchitra Krishnan-Sarin

Affiliations

  1. Yale School of Medicine, Department of Psychiatry & The Consultation Center, New Haven, CT.
  2. Yale School of Medicine, Department of Emergency Medicine, New Haven, CT.
  3. Yale School of Medicine, Department of Psychiatry, New Haven, CT.
  4. Department of Psychology, Oberlin, OH.

PMID: 29082301 PMCID: PMC5654631 DOI: 10.18001/TRS.3.1.12

Abstract

OBJECTIVE: We examined the associations between socioeconomic status (SES) and adolescent polytobacco use profiles (including e-cigarettes and blunts).

METHODS: Adolescents (N = 1932) completed surveys conducted in 2014 in 3 Connecticut high schools. Within a Latent Class Analysis (LCA) framework, logistic regressions examined associations between SES and polytobacco use profiles comprising never, ever, and current e-cigarette, blunt, cigarette, cigar, cigarillo, hookah, and smokeless tobacco use.

RESULTS: We identified 5 classes: (1) current polytobacco users; (2) ever polytobacco users; (3) current e-cigarette, blunt, and cigarette users; (4) ever e-cigarette and blunt users; and (5) never users. Low SES, relative to high SES, was associated with greater likelihood of being: (1) an ever polytobacco user; (2) a current e-cigarette, blunt, and cigarette user; and (3) an ever e-cigarette and blunt user, relative to a never user.

CONCLUSIONS: Low SES is associated with membership in distinct polytobacco use latent classes. Regulatory initiatives that focus exclusively on cigarette use may miss the opportunity to influence adolescent use of other products, which may be especially relevant to low-income individuals. Future research should examine whether targeting a broader range of products reduces SES-related tobacco use disparities.

Keywords: adolescents; latent class analysis; polytobacco use; socioeconomic status

Conflict of interest statement

Conflict of Interest Disclosure Statement: All authors of this article declare they have no conflicts of interest.

References

  1. MMWR Morb Mortal Wkly Rep. 2016 Apr 15;65(14):361-7 - PubMed
  2. Prev Med. 2002 Feb;34(2):171-8 - PubMed
  3. J Subst Abuse. 1992;4(3):219-34 - PubMed
  4. Prev Sci. 2007 Sep;8(3):206-13 - PubMed
  5. Tob Control. 2016 Mar;25(2):174-80 - PubMed
  6. Pediatrics. 2014 Aug;134(2):227-34 - PubMed
  7. Nicotine Tob Res. 2010 May;12(5):525-9 - PubMed
  8. J Adolesc Health. 2016 Feb;58(2):181-5 - PubMed
  9. Pediatrics. 2015 Aug;136(2):308-17 - PubMed
  10. Health Educ Behav. 2009 Aug;36(4):746-58 - PubMed
  11. Tob Control. 2004 Jun;13(2):115-20 - PubMed
  12. Soc Sci Med. 2008 Mar;66(6):1429-36 - PubMed
  13. J Stud Alcohol Drugs. 2007 Mar;68(2):173-81 - PubMed
  14. BMC Med Genet. 2015 Jun 26;16:43 - PubMed
  15. Am J Prev Med. 2016 Feb;50(2):199-209 - PubMed
  16. ISSBD Bull. 2015;2015(1):5-9 - PubMed
  17. Nicotine Tob Res. 2010 Jun;12(6):669-73 - PubMed
  18. Tob Control. 2016 Mar;25(2):203-10 - PubMed
  19. Drug Alcohol Depend. 2016 Apr 1;161:292-7 - PubMed
  20. BMJ Open. 2015 Apr 15;5(4):e007072 - PubMed
  21. Addiction. 2003 Oct;98(10):1379-86 - PubMed
  22. Nicotine Tob Res. 2008 Nov;10(11):1581-9 - PubMed
  23. J Adolesc Health. 2014 Jan;54(1):54-60.e9 - PubMed
  24. Am J Prev Med. 2007 Jun;32(6 Suppl):S195-202 - PubMed
  25. Arch Pediatr Adolesc Med. 2000 Nov;154(11):1089-95 - PubMed
  26. Drug Alcohol Depend. 2016 Mar 1;160:12-29 - PubMed
  27. Addict Behav. 2004 Jun;29(4):699-706 - PubMed
  28. Nicotine Tob Res. 2012 Aug;14(8):977-85 - PubMed
  29. J Prim Prev. 2011 Aug;32(3-4):161-70 - PubMed
  30. Nicotine Tob Res. 2014 Apr;16(4):454-60 - PubMed
  31. Am J Drug Alcohol Abuse. 2008;34(6):782-91 - PubMed
  32. Addict Behav. 2014 Apr;39(4):768-81 - PubMed
  33. MMWR Morb Mortal Wkly Rep. 2015 Apr 17;64(14):381-5 - PubMed
  34. Int J Public Health. 2016 Mar;61(2):199-207 - PubMed
  35. Pediatrics. 2016 Sep;138(3): - PubMed
  36. Tob Regul Sci. 2015 Oct 1;1(3):204-214 - PubMed
  37. J Behav Med. 2007 Jun;30(3):263-85 - PubMed
  38. Nicotine Tob Res. 2014 Feb;16(2):231-7 - PubMed
  39. Addict Behav. 2015 Mar;42:73-8 - PubMed
  40. Nicotine Tob Res. 2015 Jul;17(7):847-54 - PubMed
  41. Nicotine Tob Res. 2009 Jul;11(7):875-85 - PubMed
  42. Pediatrics. 2015 Mar;135(3):409-15 - PubMed
  43. Eur Addict Res. 2005;11(4):204-9 - PubMed
  44. J Stud Alcohol Drugs. 2012 Sep;73(5):772-82 - PubMed
  45. Adolescence. 2001 Winter;36(144):727-47 - PubMed
  46. Ann N Y Acad Sci. 2012 Feb;1248:107-23 - PubMed
  47. Nicotine Tob Res. 2015 Jul;17(7):810-8 - PubMed
  48. Drug Alcohol Depend. 2013 Jun 1;130(1-3):129-34 - PubMed
  49. Am J Prev Med. 2016 Oct;51(4):513-7 - PubMed
  50. Nicotine Tob Res. 2016 May;18(5):869-73 - PubMed

Publication Types

Grant support